Open access · CC-BY
via OpenAlex
Plasma and Muscle Myostatin in Relation to Type 2 Diabetes
Claus Brandt, Anders Rinnov Nielsen, Christian Philip Fischer, Jakob Bondo Hansen, Bente Klarlund Pedersen, Peter Plomgaard
PLoS ONE · 2012 · ▲ 102 citations
Abstract
OBJECTIVE: Myostatin is a secreted growth factor expressed in skeletal muscle tissue, which negatively regulates skeletal muscle mass. Recent animal studies suggest a role for myostatin in insulin resistance. We evaluated the possible metabolic role of myostatin in patients with type 2 diabetes and healthy controls. DESIGN: 76 patients with type 2 diabetes and 92 control subjects were included in the study. They were matched for age, gender and BMI. Plasma samples and biopsies from the vastus lateralis muscle were obtained to assess plasma myostatin and expression of myostatin in skeletal muscle. RESULTS: Patients with type 2 diabetes had higher fasting glucose (8.9 versus 5.1 mmol/L, P<0.001), plasma insulin (68.2 versus 47.2 pmol/L, P<0.002) and HOMA2-IR (1.6 versus 0.9, P<0.0001) when compared to controls. Patients with type 2 diabetes had 1.4 (P<0.01) higher levels of muscle myostatin mRNA content than the control subjects. Plasma myostatin concentrations did not differ between patients with type 2 diabetes and controls. In healthy controls, muscle myostatin mRNA correlated with HOMA2-IR (r = 0.30, P<0.01), plasma IL-6 (r = 0.34, P<0.05) and VO2 max (r = -0.26, P<0.05), however, no correlations were observed in patients with type 2 diabetes. CONCLUSIONS: This study supports the idea that myostatin may have a negative effect on metabolism. However, the metabolic effect of myostatin appears to be overruled by other factors in patients with type 2 diabetes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pone.0037236
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Brandt, C., Nielsen, A.R., Fischer, C.P., Hansen, J.B., Pedersen, B.K., & Plomgaard, P. (2012). Plasma and Muscle Myostatin in Relation to Type 2 Diabetes. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0037236
Vancouver
Brandt C, Nielsen AR, Fischer CP, Hansen JB, Pedersen BK, Plomgaard P. Plasma and Muscle Myostatin in Relation to Type 2 Diabetes. PLoS ONE. 2012. doi:10.1371/journal.pone.0037236.
BibTeX
@article{claus2012Plasma,
title = {Plasma and Muscle Myostatin in Relation to Type 2 Diabetes},
author = {Claus Brandt and Anders Rinnov Nielsen and Christian Philip Fischer and Jakob Bondo Hansen and Bente Klarlund Pedersen and Peter Plomgaard},
journal = {PLoS ONE},
year = {2012},
doi = {10.1371/journal.pone.0037236},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ain Shams University 2025
Open access · US-GOV
The Relation Between Diabetic Neuropathy and Muscle Mass in Type 2 Diabetes Mellitus Patients
Diabetologia 2007
Open access · CC-BY
Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle
Diabetes Care 2007
Citation only
The Relationship Between Adrenomedullin, Metabolic Factors, and Vascular Function in Individuals With Type 2 Diabetes
Frontiers in Nutrition 2024
Open access · CC-BY
The effects of different intermittent fasting regimens in people with type 2 diabetes: a network meta-analysis
Diabetes 2002
Open access · OA
Association of Adiponectin Mutation With Type 2 Diabetes
Journal of Clinical Medicine 2025
Open access · CC-BY